Fundraising Fox
/Companies
Sign in

Korsana

Waltham, US · 32 employees on LinkedIn · 7 known investors

Find your way into Korsana

Sign up to see every warm intro you have to Korsana

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Korsana team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Korsana develops technology to deliver large-molecule biologic drugs across the blood-brain barrier using transferrin receptor shuttling, aimed at treating neurodegenerative diseases such as Alzheimer's. Its approach uses antibody engineering to enable therapies with meaningful central nervous system exposure delivered subcutaneously.

BiotechDeep TechHealthtech

Founders & leadership

MVMark Vignola
Mark VignolaChief Financial OfficerMark Vignola is Chief Financial Officer of Korsana and holds a PhD in molecular biology with a background in biotechnology.
JVJonathan Violin
Jonathan ViolinPresidentJonathan Violin is President of Korsana, which develops technology to deliver biologic drugs across the blood-brain barrier for neurodegenerative disease treatment. He has held CEO and board roles at biotech companies and has experience in drug discovery, scientific platform development, and capital raising.

Investors · 7

TCG Crossoverlisted by TCG CrossoverPalo Alto
Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M

How we know: statnews.com · Not right? Tell us

VenrockreportedPalo Alto · $500K – $10M

How we know: statnews.com · Not right? Tell us

Also in the syndicate · 3

FairmountJ.P. Morgan Life Sciences Private CapitalTCGX

Funding

SEC filings, press & company announcements

$325M disclosed across 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

4 people who came through Korsana went on to found or lead other companies.

Jonathan ViolinPresidentFounded Viridian Therapeutics +1Nimish ShahCo-Founder and Board DirectorFounded Apogee TherapeuticsAndrew GottesdienerCo-Founder and Board MemberFounded Apogee TherapeuticsKatharine von HerrmannSr. Director, R&D Strategy and OperationsFounded Etiome

In the news

Korsana Biosciences Raises $175M in Fundingfinsmes.com · Feb 2026

Frequently asked questions

What does Korsana do?
Korsana develops technology to deliver large-molecule biologic drugs across the blood-brain barrier using transferrin receptor shuttling, aimed at treating neurodegenerative diseases such as Alzheimer's. Its approach uses antibody engineering to enable therapies with meaningful central nervous system exposure delivered subcutaneously.
Who are Korsana's investors?
Korsana's investors include Sanofi Ventures, TCG Crossover, Wellington Management, Venrock.
How much funding has Korsana raised?
Korsana has disclosed $325M raised across 2 rounds.
Where is Korsana headquartered?
Korsana is headquartered in Waltham, US.